Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
×
Abstract: In ovarian cancer treatment there is no single standard criterion adopted for chemotherapy responses assessment. CA-125 is widely used to evaluate ...
Use of CA-125 to assess response to new agents in ovarian cancer trials. · Defining response of ovarian carcinoma to initial chemotherapy according to serum CA ...
People also ask
A Monte Carlo Reliability Study of the Assessment of Chemotherapy Responses in Ovarian Cancer Treatment. BMEI 2009: 1-4. [+][–]. Coauthor network. maximize.
Evidence for the clinical effectiveness of topotecan, PLDH, paclitaxel, trabectedin and gemcitabine was assessed by conducting a systematic review of ...
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study.
People also search for
Treatments for ovarian cancer
For informational purposes only. Consult your local medical authority for advice.
An across Factor Normalization Based SVD Approach to Analysis of Gene Expression Profiles for Uncovering Biomarkers in Ovarian Carcinoma Chemotherapy Responses.
Oct 23, 2014 · A cost-utility analysis of an NRG Oncology/Gynecologic Oncology Group Protocol 218: Incorporating prospectively collected Quality-of-life scores ...
This study demonstrated the feasibility of analyzing quantitative image features to improve the early predicting accuracy of the tumor response to the new ...
In the present study, we show that cIAP protein levels, evaluated by in situ proteomic analysis, predict for patient outcome in a cohort of chemotherapy-treated ...
... Monte Carlo P value for the optimal cut point generated. ... p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer.